FDA NDC Directory · JSON-LD · Markdown

Garzulys

NDC 71288-904 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameinsulin aspart-fsan
Labeler / ManufacturerMeitheal Pharmaceuticals Inc.
Marketing categoryBiologic License Application · App BLA761497
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsINSULIN ASPART (100 [iU]/mL)
Marketing started20260724
Package count1

External sources

Source: openFDA. Public-domain (CC0).